Industry & Business

TCD bio-pharma company sold for over €5m

 Breaking News
  • TechConnect Live – RDS, Dublin – May 30th, 2018 TechConnect Live, Ireland’s largest technology event, is expected to attract over 3,000 visitors from across the Irish and international tech sector to the RDS, Dublin on 30th of May 2018. TechConnect Live provides a unique forum for technology companies, start-ups, investors and the largest Irish and global end users of technology and services in order [...]...
  • Ornua Delivers Record Revenue Ornua, Ireland’s largest exporter of Irish dairy products which supplies to over 110 countries worldwide, has reported record revenue of €2.1 billion for the year ended 30 December 2017. It marks the first year of Ornua’s new five-year growth plan, ‘Ornua 2021’, which positions the business as a leading global dairy organisation that delivers results [...]...
  • EPA Welcomes Increase in Composting and Anaerobic Digestion of Waste The EPA has released data and information on composting and anaerobic digestion in Ireland for 2016. The data updates the National Waste Statistics web resource, launched by the EPA in recent months. Commenting on the figures, Stephen Treacy, EPA, said: “The EPA welcomes the increase in the amount of biodegradable waste being accepted for recycling at composting [...]...
  • Revised Research Priority Areas For 2018-2023 The Government has published the ‘Research Priority Areas 2018–2023’ report. Research Prioritisation, introduced by the Government in 2012, aligns the majority of competitively awarded public investment in research with 14 priority areas. Innovation 2020, Ireland’s strategy for research and development, science and technology, commits to reviewing the priority areas to ensure that they are still valid [...]...
  • Brexit Price Increases Could Affect Poorer Households Most A hard Brexit would increase the cost of living for all households in Ireland by 2 per cent to 3.1 per cent – an annual increase of €892 to €1,360 per household, according to the Competition and Consumer Protection Commission. Costs would rise the most for lower-income households. These households spend a greater share of [...]...

TCD bio-pharma company sold for over €5m

March 09
12:38 2016

pharma_chemie_jobs_labA Trinity College Dublin spin-off bio-pharma company has been sold to a US firm for €5.4m and 265,000 shares.

Genable Technologies, which makes gene-based drugs that treat genetic diseases, has been purchased by Spark Therapeutics – an American firm considered a leader in gene therapy.

Genable was set up on campus in Trinity 13 years ago out of the research of Professor Jane Farrar, Dr Paul Kenna and Professor Peter Humphries.

It is expected that the takeover will lead to the research that Genable has worked on being converted into products approved for market.

Among the likely candidates is RhoNova, a potential treatment that targets a form of the eye disease retinitis pigmentosa which can result in visual impairment and even blindness.

The two companies have been working together in the area of inherited retinal disease for the past two years.

“Without doubt at this juncture Spark Therapeutics provides the optimal way for this innovative therapy to progress to patients,” said Professor of Genetics at Trinity, Jane Farrar, who has been involved in building Genable.

According to Trinity College Dublin, shareholders in Genable will receive $6 million following the sale, along with 265,000 shares of Spark common stock.

It did not disclose the other financial terms that are part of the deal.

Among those who have supported and invested in the company are Fountain Healthcare Partners, Delta Partners, Fighting Blindness Ireland, Foundation Fighting Blindness Clinical Research Institute (US) and Enterprise Ireland.

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4